Turn this list into pipeline.
Medical Devices Companies in Bristol: 46 Active Firms (2026)
Medical device companies design, manufacture or distribute regulated healthcare products for clinical and patient use across Bristol.
Buying centres tend to sit in clinical procurement, laboratory operations, quality assurance and healthcare supply-chain teams, rather than a single technology budget. The customer base is mainly B2B and public-sector-adjacent: hospitals, clinics, laboratories, care providers, distributors and service partners that need traceable products, maintenance cover and documentation suitable for clinical governance. Engagements are usually specialist and evidence-led, with buyers asking about conformity assessment, product marking, servicing obligations and post-market responsibilities before commercial fit. For smaller Bristol suppliers, route-to-market often depends as much on distributor access and quality-system credibility as on product design.
Read more
Bristol has 46 actively trading medical device companies in this list, a compact local cohort within a sector that often relies on specialist manufacturing, testing, distribution and servicing capabilities. The reported employment footprint is 203 people, concentrated across the 30 firms that disclose headcount. Scale is uneven: 3 companies report turnover above £5M, while 8 have been incorporated since 2022. That mix points to a market with a small number of revenue-ranked scale businesses and a longer tail of specialist SMEs.
MHRA sits at the centre of Great Britain market access for medical devices, including in vitro diagnostics, custom-made devices and systems or procedure packs. GOV.UK guidance requires registration before devices are placed on the Great Britain market, alongside the relevant conformity-assessment and product-marking route. UKCA marking is the domestic route, while transitional rules still allow some CE-marked devices to be placed on the market for certain regimes. Non-UK manufacturers need a UK responsible person, and Northern Ireland follows separate EU-derived device rules. The Association of British HealthTech Industries is a relevant trade body reference point for health technology suppliers.
Bristol’s cohort appears SME-weighted, with a small scale-up tail and a group of younger entrants still working through validation, distribution access and quality-system maturity. Demand tends to be shaped by clinical procurement caution, servicing expectations and documentation burden, so firms with narrow product scope may remain commercially viable without becoming broad platform suppliers. Consolidation is more likely to come through distribution partnerships, outsourced manufacturing and specialist service relationships than through consumer-style brand building. Regulatory pressure should keep the barrier to casual entry relatively high.
46
Active firms
2026
3
Above £5M
turnover threshold
8
New incorporations
since 2022
Key facts
About 6% of the trading cohort reports turnover above £5M (3 of 46 firms) — the rest sits below that revenue band.
17% of the cohort was incorporated since 2022 (8 firms), so a sizeable share is in its first few filing cycles.
Medical devices, in vitro diagnostics, custom-made devices and systems or procedure packs must be registered with the MHRA before being placed on the Great Britain market.
Great Britain's main framework is the Medical Devices Regulations 2002 (SI 2002 No 618, as amended).
UKCA marking is the domestic route for Great Britain, while transitional rules allow certain CE-marked devices until 30 June 2028 or 30 June 2030, depending on device regime.
The Office for Life Sciences estimated the UK medical technology subsector at 4,360 companies in 2023/2024, generating £48.0 billion in turnover.
Europe's medical technology market was roughly €170 billion in 2024, representing 26.4% of the world market; the US accounted for 46.4%.
Top Bristol medical devices companies
Genomic Labs Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops in vitro diagnostic devices for rapid detection and identification of bacteria in blood samples. Technology analyses pathogens and antimicrobial resistance profiles to help clinicians select…
Serves hospitals, clinicians, microbiology teams and healthcare organisations involved in sepsis care and antimicrobial resistance management, with partnerships across the healthcare diagnostics…
Financial Health
StrongStrong · Growing, Hiring · 36% CAGR over 4y
Location
Cyclomedica United Kingdom Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsSupplies nuclear medicine imaging technology for pulmonary diagnostics, including the Technegas system used in ventilation imaging to assess lung function and detect conditions such as pulmonary…
Serves hospitals, nuclear medicine and molecular imaging departments, radiology teams and respiratory clinicians involved in pulmonary care, with distribution to healthcare providers in 65 countries.
Financial Health
StrongStrong · Hiring · 22% CAGR over 2y
Location
BES HEALTHCARE LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · 2% CAGR over 4y
Location
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsDevelops and manufactures hyaluronic acid‑based orthopedic products for regenerative medicine and osteoarthritis treatment, including viscosupplement injections, cartilage repair scaffolds, bone…
Serves orthopedic surgeons, sports medicine clinicians, hospitals and clinics treating osteoarthritis and soft-tissue or bone injuries, with patient-facing resources for people seeking care worldwide.
Financial Health
WeakWeak · -18% CAGR over 1y
Location
NEUROCHASE LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops drug delivery systems for the central nervous system, including convection‑enhanced delivery devices for gene and other therapeutics. Provides consultancy, protocol development, training,…
Serves biotech and pharmaceutical companies developing CNS therapies, as well as CROs and clinical trial teams involved in neurological disease programmes.
Financial Health
StableStable · -7% CAGR over 2y
Location
Biomet 3i UK Ltd
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops and supplies dental implant systems, biomaterials, surgical tools, restorative components and digital dentistry software. Provides guided surgery solutions, site preparation instruments, and…
Serves dental professionals and practices worldwide, including implant dentists, oral surgeons, restorative clinicians, dental labs, and practice teams seeking implantology, digital workflow,…
Financial Health
StrongStrong · Hiring · 16% CAGR over 5y
Location
EMPATHICA UK LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDesigns and develops medical wearable devices, AI algorithms and software for remote patient monitoring and digital biomarkers. Provides platforms that collect physiological data for clinical…
Sells to researchers and clinicians, especially clinical trial teams and pharmaceutical companies using remote patient monitoring and digital biomarkers across therapeutic areas such as neurology and…
Financial Health
HealthyHealthy · -25% CAGR over 2y
Location
Airway Medical Ltd
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
Staplebarn Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak
Location
Innotive Diagnostics Limited
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsDevelops point‑of‑care diagnostic tests for urinary tract infections, providing on‑site detection of bacterial pathogens and antimicrobial susceptibility within about an hour. Focuses on research and…
Serves healthcare providers and clinical settings treating patients with uncomplicated UTIs, particularly point-of-care teams seeking rapid antimicrobial susceptibility results without relying on…
Financial Health
StrongStrong · Hiring · 64% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops rapid point‑of‑care diagnostic technologies for detecting infections and guiding antibiotic selection. Its platforms, including VERI-5 and SCFI, analyse patient samples to identify pathogens…
Serves doctors, clinicians and small-animal veterinary practices involved in infection management and antibiotic prescribing, with an emphasis on point-of-care settings and UTI care.
Financial Health
StableStable · Hiring · 3% CAGR over 4y
Location
SOMNUS SCIENTIFIC LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
ALPHA ME LTD
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
DistressedDistressed · 0% CAGR over 1y
Location
RIPPLEFFECT MEDICAL LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable
Location
HANHAM DENTAL LABORATORY LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · -68% CAGR over 4y
Location
NADINA N LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
TwoBones Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · 0% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies medical devices and consumables for healthcare facilities, including urology and incontinence products, urine drainage and catheter systems, nursing and hygiene supplies, examination gloves,…
Serves B2B healthcare providers and facility buyers, including hospitals, critical-care wards, nursing and care settings, and organisations managing urology, incontinence, hygiene and…
Financial Health
WeakWeak
Location
DEVICE SCOPE LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · -65% CAGR over 4y
Location
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
DistressedDistressed · 0% CAGR over 1y
Location
EMDC Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak
Location
INGENIUMAI LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops machine learning software integrated with hospital systems to analyse existing clinical tests and imaging data, identifying signs of disease and alerting clinicians to patients who may…
Sells to healthcare providers and hospital systems, including clinicians and diagnostic teams seeking support for faster disease detection using existing clinical scans and tests.
Financial Health
StrongStrong · Hiring · 26% CAGR over 2y
Location
Alivio Technology Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsFinancial Health
DistressedDistressed · 0% CAGR over 2y
Location
Lumendi Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops endoluminal surgical devices for gastrointestinal endoscopy, including the DiLumen platform and accessories that attach to endoscopes to improve navigation, tissue manipulation, and…
Sells to B2B healthcare customers, especially gastrointestinal and colorectal physicians and endoscopy teams performing lower GI procedures such as complex polypectomies, EMR, ESD and colonoscopies.
Financial Health
WeakWeak · Hiring · 15% CAGR over 2y
Location
ENERGY FOR HEALTH LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · Hiring · 19% CAGR over 4y
Location
Meril UK Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures medical devices and healthcare technologies across specialties including cardiovascular, orthopaedics, robotics, diagnostics and oncology. Supplies devices to healthcare…
Serves B2B healthcare providers, hospitals and clinicians worldwide, particularly specialists in cardiovascular care, orthopedics, robotics, diagnostics and oncology.
Financial Health
HealthyHealthy
Location
PC Edwards Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and manufactures medical devices for treating structural heart disease, including transcatheter heart valves, mitral and tricuspid repair technologies, surgical valve systems, and…
Serves healthcare providers and institutions, especially cardiac heart teams, cardiologists and surgical specialists treating patients with structural heart and cardiovascular disease; also addresses…
Financial Health
WeakWeak · 0% CAGR over 4y
Location
Microscopes South West Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StrongStrong · Growing · 0% CAGR over 4y
Location
Unlock all 46 leads
Showing 28 of 46 — +18 more with verified decision-maker contacts, live data, and CRM sync.
How Bristol medical devices companies work and how to sell to them
What they do
Bristol medical device suppliers usually earn revenue through a mix of unit sales, repeat consumables, service contracts, testing work, distribution margins and specialist assembly. Some sell finished devices into healthcare channels; others support device makers with design-for-manufacture, quality documentation, servicing or component supply. Pricing tends to follow the product risk and support burden: low-value consumables may be bought through repeat orders, while capital equipment, custom-made devices and service packages are more likely to involve quotations, technical review and negotiated terms. Margins depend on traceability, conformity work and after-sales obligations as much as on the physical product itself.
Who they sell to
Typical customers are hospitals, clinics, laboratories, care providers, distributors and healthcare supply-chain partners. The buying group is usually mixed, with clinical procurement, laboratory operations, quality assurance, technical services and supply-chain teams all able to slow or shape a purchase. Smaller device suppliers often sell through direct relationships or distributors, while larger or public-sector-adjacent opportunities tend to involve formal procurement, supplier onboarding and evidence packs. Sales cycles are rarely purely transactional: buyers usually want product marking status, maintenance arrangements, training requirements, documentation quality and continuity of supply resolved before price becomes the main negotiation point.
What they buy
Most Bristol medical device firms tend to spend on quality-management systems, document control, regulatory consulting, product testing, calibration, stock and batch traceability, field-service management and finance operations. Firms that manufacture or assemble devices may also need production planning, inspection equipment, clean handling processes, specialist recruitment and outsourced technical support. Distributor-led businesses tend to buy CRM, quoting tools, inventory management, customer support systems and marketing services aimed at clinical or laboratory buyers. Security, backup and access controls matter where technical files, customer records and service histories sit in cloud systems or shared operational software.
Why and how to sell to them
Buying intent often appears when a device firm is preparing a new product route, adding a distributor, moving from prototype to repeat supply, appointing a quality or operations lead, or facing heavier documentation and servicing demands. Regulatory change, audit findings and customer onboarding requests can also create budget where general efficiency messaging would not. Sellers usually have a better opening when they tie the pitch to traceability, compliance evidence, fewer manual handovers, faster quotation-to-delivery, or lower risk in post-market support. Generic growth language is less persuasive than showing how the offer fits clinical procurement scrutiny and the firm’s quality system.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Bristol
Related directories
Frequently asked questions
How many medical devices companies are there in the Bristol?↓
What counts as a medical devices company in this list?↓
Which are the largest medical devices companies in the Bristol?↓
What do medical devices companies in the Bristol actually do?↓
How does Bristol medical devices compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical medical devices companies in the Bristol?↓
Are these mostly new or established medical devices companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 46 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.